These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

77 related items for PubMed ID: 611014

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Malignant neuroleptics syndrome].
    Pirovino M, Meier J, Meyer M, Waldmeier P, Schmid M.
    Dtsch Med Wochenschr; 1984 Mar 09; 109(10):378-81. PubMed ID: 6697897
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Neuroleptic malignant syndrome. Case reports].
    Berardi D, Troia M, Veronesi L, Ferrari G.
    Minerva Psichiatr; 1994 Dec 09; 35(4):199-219. PubMed ID: 7861943
    [Abstract] [Full Text] [Related]

  • 6. The neuroleptic malignant syndrome.
    Schrader G, Wong C, Russell R, Goldney RD.
    Med J Aust; 1981 Oct 31; 2(9):494. PubMed ID: 6119606
    [Abstract] [Full Text] [Related]

  • 7. The neuroleptic malignant syndrome.
    Caroff SN.
    J Clin Psychiatry; 1980 Mar 31; 41(3):79-83. PubMed ID: 6101595
    [Abstract] [Full Text] [Related]

  • 8. Beneficial effects of dantrolene in the treatment of neuroleptic malignant syndrome: a report of two cases.
    Goulon M, de Rohan-Chabot P, Elkharrat D, Gajdos P, Bismuth C, Conso F.
    Neurology; 1983 Apr 31; 33(4):516-8. PubMed ID: 6682201
    [Abstract] [Full Text] [Related]

  • 9. ["Heat stroke" and/or "Malin's syndrome" in a patient treated with fluphenazine decanoate].
    Ginestet D, Plumecoq C, Farine K, Brion S.
    Encephale; 1977 Apr 31; 3(4):327-31. PubMed ID: 611015
    [Abstract] [Full Text] [Related]

  • 10. The neuroleptic malignant syndrome.
    Smego RA, Durack DT.
    Arch Intern Med; 1982 Jun 31; 142(6):1183-5. PubMed ID: 6124221
    [Abstract] [Full Text] [Related]

  • 11. [Rhabdomyolysis with acute renal failure and malignant neuroleptic syndrome].
    Kleinknecht D, Parent A, Blot P, Bochereau G, Lallement PY, Pourriat JL.
    Ann Med Interne (Paris); 1982 Jun 31; 133(8):549-52. PubMed ID: 6133493
    [Abstract] [Full Text] [Related]

  • 12. Fluphenazine-induced neuroleptic malignant syndrome in a schizophrenic patient.
    Aruna AS, Murungi JH.
    Ann Pharmacother; 2005 Jun 31; 39(6):1131-5. PubMed ID: 15840734
    [Abstract] [Full Text] [Related]

  • 13. Masseter muscle rigidity and malignant hyperthermia susceptibility.
    Rosenberg H, Fletcher JE.
    Anesth Analg; 1986 Feb 31; 65(2):161-4. PubMed ID: 3942303
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Neuroleptic malignant syndrome due to depot fluphenazine.
    Grunhaus L, Sancovici S, Rimon R.
    J Clin Psychiatry; 1979 Feb 31; 40(2):99-100. PubMed ID: 762037
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Cardiac arrhythmia associated with malignant neuroleptic syndrome: description of 2 clinical cases].
    Cordioli E, Pizzi C, Tondini C.
    G Ital Cardiol; 1997 Nov 31; 27(11):1164-8. PubMed ID: 9463060
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.